VITA Grow is a children’s immunity brand owned by the same group behind Ameri-Vita, with a product concept centred on yeast β-glucan-based immune nutrition. The brief has been to support the development of the range for the UK and EU marketplaces, helping translate the brand concept into products that are suitable for local regulatory and market requirements while maintaining the premium positioning of the brand. Public brand messaging highlights infant and child immune nutrition, with a core focus on its Liquid Yeast β-Glucan Active Immunity Series.

The VITA Grow range is built around immune support for infants and children, with yeast β-glucan positioned as the key functional ingredient. The brand highlights its KAREMUNE® allergy-free liquid glucan technology, developed with academic research support and designed for improved absorption and child-friendly use. One publicly listed product is a Yeast β-Glucan Softgel for children, containing yeast β-glucan, zinc and vitamin D in a format that can be chewed, swallowed or mixed with food, reflecting the brand’s focus on convenience as well as formulation quality.

As part of the work to bring the VITA Grow children’s range to the UK and EU, the project supports the expansion of the brand into new regulated marketplaces. By aligning the range with local compliance requirements while preserving the brand’s core positioning around premium child immune nutrition, the customer is able to launch the range across the UK and Europe. The partnership also supports continuity across the wider brand portfolio, with VITA Grow sitting alongside Ameri-Vita under the same ownership structure.